1-3 of 3
Kimberly Hayes
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Myelodysplasia and acute myeloid leukemia following therapy for indolent lymphoma with fludarabine, mitoxantrone, and dexamethasone (FND) plus rituximab and interferon alpha

Free
Clinical Trials & Observations
Peter McLaughlin, Elihu Estey, Armand Glassman, Jorge Romaguera, Felipe Samaniego, Ana Ayala, Kimberly Hayes, Anne Marie Maddox, H. Alejandro Preti, Fredrick B. Hagemeister
Journal: Blood
Blood (2005) 105 (12): 4573–4575.
https://doi.org/10.1182/blood-2004-08-3035
Published: 2005
Journal Articles

Imatinib mesylate therapy may overcome the poor prognostic significance of deletions of derivative chromosome 9 in patients with chronic myelogenous leukemia

Free
Clinical Trials & Observations
Alfonso Quintas-Cardama, Hagop Kantarjian, Moshe Talpaz, Susan O'Brien, Guillermo Garcia-Manero, Srdan Verstovsek, Mary Beth Rios, Kimberly Hayes, Armand Glassman, B. Nebiyou Bekele, Xian Zhou, Jorge Cortes
Journal: Blood
Blood (2005) 105 (6): 2281–2286.
https://doi.org/10.1182/blood-2004-06-2208
Published: 2005
Journal Articles

Myelodysplasia and Acute Myeloid Leukemia Following Therapy for Indolent Lymphoma with Fludarabine, Mitoxantrone, Dexamethasone (FND) Plus Rituximab and Interferon Alfa.

Free
Peter McLaughlin, MD, Elihu Estey, MD, Armand Glassman, MD, Jorge Romaguera, MD, Felipe Samaniego, MD, PhD, Ana Ayala, RN, Kimberly Hayes, Anne Marie Maddox, MD, PhD, H. Alejandro Preti, MD, Fredrick B. Hagemeister, MD
Journal: Blood
Blood (2004) 104 (11): 1394.
https://doi.org/10.1182/blood.V104.11.1394.1394
Published: 2004